د. جلال نفاش

Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study

Liraglutide as Add-on to Sodium-glucose Co-transporter-2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes: LIRA-ADD2SGLT2i, a 26-week, Randomized, Double-blind, Placebo-controlled Trial

Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in United Arab Emirates Patients with Type 2 Diabetes